My price target of 45-50c is still my price target although it has been diluted to 35-40c due to the CR back in March....
This price target, valuing the company at around $600-700 million dollars, is dependent on positive vaccine results and strongly growing CardioCel sales.....
Lex, I don't change my mind on a company's value depending on what the share price is doing. My valuation depends on what progress the company is making. So my posts have always been in good faith, I've never tried to talk the share price up or down depending on whether I am buying or selling (I've never sold) ...
I'll repeat again "dependent on positive vaccine results and strongly growing CardioCel sales" my valuation for the future is 35-40c.
No obfuscation or duplicity on my part Lex.
Consolidation, page-155
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.06 |
Change
-0.440(3.83%) |
Mkt cap ! $232.5M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $11.50 | $10.91 | $86.36K | 7.811K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22 | $11.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.13 | 549 | 5 |
View Market Depth
| Last trade - 13.33pm 17/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |